1 University of Coimbra, Center for Neuroscience and Cell Biology, Portugal 2 University of Coimbra, Institute of Biochemistry, Faculty of Medicine, Portugal Alzheimer’s disease (AD) is the leading ...

Abstract: Automatic modulation recognition of unknown signals is key technology in cognitive radio and military systems. However, low recognition accuracy under low signal-to-noise ratio (SNR) ...

Some serious brain disorders begin with symptoms that are easy to misinterpret. A person may become confused, forgetful or paranoid and be treated for mental illness before doctors realize the ...

A new study published in Science Advances describes a potential target for therapies aimed at treating anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis, also known as ‘Brain on Fire,’ an ...

Unequal modulation (UEQM) in Wi-Fi 8 refers to the ability to assign different modulation orders to different spatial streams in a Multi-Input Multi-Output (MIMO) connection based on each stream’s ...

Mohsen Baqery is a Staff Writer at GameRant based in Turkey. He mainly covers video game news and industry features while occasionally publishing guides and listicles. Mohsen started his journey into ...

Abstract: The data transmission security and power consumption are the main challenges for Internet of Things (IoT) devices. Backscatter directional modulation (DM) techniques have emerged as a ...

Pulse density modulation (PDM) is a compact digital audio format used in devices like MEMS microphones and embedded systems. This compact primer eases you into the essentials of PDM audio. Let’s begin ...

Pfizer is launching the first clinical trials for its PD-1xVEGF drug, while Akeso detailed the first overall survival win for its first-in-class ivonescimab. Eli Lilly signed two more drug discovery ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

Another of the psychiatry drugs Neurocrine Biosciences licensed from Takeda has stumbled in the clinic. The latest midstage flop comes from NBI-1070770, a negative allosteric modulator of the NR2B ...